Neuronetics awards 250,000 RSUs to finance chief

Neuronetics, Inc. reported that EVP, CFO and Treasurer Steven Pfanstiel acquired an award of 250,000 shares of common stock in the form of restricted stock units.

Rhea-AI Filing Summary

Neuronetics, Inc. reported that EVP, CFO and Treasurer Steven Pfanstiel acquired an award of 250,000 shares of common stock in the form of restricted stock units. The award was granted at no purchase price.

The RSUs vest in three equal annual installments beginning on February 23, 2027, as long as he remains in continuous service through each vesting date. After this grant, his directly held common stock position reported in the filing totals 820,212 shares.

Insider Trade Summary

Grant/Award: 250,000 shares

Grant/Award 1 txn

Insider Pfanstiel Steven

Role EVP, CFO and Treasurer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	250,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 820,212 shares (Direct)

Footnotes (2)

1. F1. Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 23, 2027, in each case subject to continuous service of the Reporting Person through such date.
2. F2. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Neuronetics (STIM) disclose in this Form 4 filing?

Neuronetics disclosed a stock-based compensation award to its EVP, CFO and Treasurer, Steven Pfanstiel. He received 250,000 restricted stock units of common stock, which vest over time, increasing his reported direct holding to 820,212 shares after the grant.

How many RSUs did Neuronetics (STIM) grant to its CFO?

Neuronetics granted 250,000 restricted stock units to EVP, CFO and Treasurer Steven Pfanstiel. Each RSU represents a contingent right to receive one share of Neuronetics’ common stock, subject to the vesting schedule and his continued service with the company.

What is the vesting schedule for the Neuronetics (STIM) CFO’s RSU award?

The 250,000 restricted stock units vest in three equal annual installments starting on February 23, 2027. Each tranche requires Steven Pfanstiel to remain in continuous service with Neuronetics through the applicable vesting date before the shares are delivered.

Did the Neuronetics (STIM) CFO pay for the RSU shares granted?

The Form 4 shows a transaction price per share of $0.0000, indicating the RSU award was granted at no cash purchase price. This reflects stock-based compensation, where value is delivered in equity that vests over time, rather than a market purchase.

How many Neuronetics (STIM) shares does the CFO hold after this RSU grant?

Following the RSU award, the Form 4 reports that Steven Pfanstiel’s total directly held common stock position is 820,212 shares. This figure reflects his holdings after recording the 250,000-share restricted stock unit grant on the non-derivative table.

What does each Neuronetics (STIM) RSU granted to the CFO represent?

Each restricted stock unit represents a contingent right to receive one share of Neuronetics common stock. The rights convert into actual shares only as they vest, and vesting depends on Steven Pfanstiel’s continuous service through each future vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 04:30 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pfanstiel Steven

(Last) (First) (Middle)

C/O NEURONETICS, INC.

3222 PHOENIXVILLE PIKE

(Street)

MALVERN PA 19355

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CFO and Treasurer

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/23/2026		A		250,000(1)	A	$0(2)	820,212	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 23, 2027, in each case subject to continuous service of the Reporting Person through such date.

2. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

	/s/ Patrick Devine, as Attorney-in-Fact	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.